NAVIFUS CORPORATION
Update：2026/08/06
Industries
Main Industry
Health Care
Main Product/Service
1. NaviFUS® Neuronavigator-guided transcranial focused ultrasound system
2. NAVIRFA® Needle Tracking System
2. NAVIRFA® Needle Tracking System
Founded Year
2015
Unified Business No.
24731239
Status
Active
Number of Employees
0
Total Paid-in
Capital
707,505,110 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
Emerging Stock Exchange(2022)、OTC listing(2025)
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
As a biotech company, NaviFUS provides novel platform solutions for enhancing the delivery of oncology drugs across the blood-brain barrier. The company's product NaviFUS System utilizes non-invasive ultrasound energy, the NaviFUS System increases BBB permeability transiently and safely, facilitating targeted delivery of small or largemolecular CNS drugs. The company's focus is on helping CNS disease patients globally by supplying therapeutic ultrasound technologies for clinical use through partnerships with global pharmaceutical companies.
